National registry for Chinese patients with cystic fibrosis
A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Cystic Fibrosis (CF-CHINA)
This study is trying to create a national registry for cystic fibrosis patients in China to better understand their health and treatment needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT05289245 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a national registry for cystic fibrosis (CF) patients in China, focusing on understanding the prevalence, disease status, diagnosis, treatment, quality of care, and health-related outcomes. Given the rarity of CF in the Chinese population, this study seeks to fill the knowledge gap by collecting comprehensive data on affected individuals. The study will involve patients who meet specific clinical criteria and are in a stable health phase, ensuring accurate and relevant data collection.
Who should consider this trial
Good fit: Ideal candidates for this study are Chinese patients who have been diagnosed with cystic fibrosis and are in a stable health phase.
Not a fit: Patients with other forms of bronchiectasis or those with severe cardiac or renal diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of cystic fibrosis in the Chinese population, leading to improved patient care.
How similar studies have performed: While there is limited literature on cystic fibrosis in the Chinese population, similar registries in other countries have successfully improved understanding and treatment of the disease.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Fulfilled WHO clinical diagnostic criteria for CF; Was in a stable phase with no respiratory infections for nearly 4 weeks; Subjects (or their guardians) signed informed consent. Exclusion Criteria: Patients with other bronchiectasis who did not meet the inclusion criteria; Those with severe cardiac or renal disease
Where this trial is running
Beijing, Beijing Municipality
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Xinlun Tian, M.D.
- Email: tianxl@pumch.cn
- Phone: 86-10-69155039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.